We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+0.28%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$360B
AUM Growth
-$5.05B
Cap. Flow
-$2.61B
Cap. Flow %
-0.72%
Top 10 Hldgs %
13.81%
Holding
6,930
New
170
Increased
3,227
Reduced
2,806
Closed
155

Sector Composition

Rank Sector Weight
1 Technology 11.4%
2 Financials 10.07%
3 Consumer Discretionary 8.39%
4 Healthcare 7.69%
5 Communication Services 6.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WWR icon
6501
Westwater Resources
WWR
$52.1M
0
XCEM icon
6502
Columbia EM Core ex-China ETF
XCEM
$1.88B
-50
Closed -$1K
YCBD icon
6503
cbdMD
YCBD
$4.94M
0
QXO
6504
QXO Inc
QXO
$14B
0
ORKA
6505
Oruka Therapeutics
ORKA
$5.9B
$0 ﹤0.01%
+1
New +$268
SUNE
6506
SUNation Energy
SUNE
$9.44M
0
-$5K
ABLG
6507
Abacus FCF International Leaders ETF
ABLG
$16M
-40
Closed -$1K
ABFL
6508
Abacus FCF Leaders ETF
ABFL
$520M
-35
Closed -$1K
TGEN
6509
Tecogen Inc
TGEN
$95.7M
$0 ﹤0.01%
101
ATXI
6510
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
0
ICCH
6511
DELISTED
ICC Holdings, Inc.
ICCH
$0 ﹤0.01%
1
WHLM
6512
DELISTED
Wilhelmina International, Inc
WHLM
$0 ﹤0.01%
16
ENSV
6513
DELISTED
Enservco Corp.
ENSV
0
SEEL
6514
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0
ALIM
6515
DELISTED
Alimera Sciences
ALIM
$0 ﹤0.01%
27
LSXMB
6516
DELISTED
Liberty Media Corporation Series B Liberty SiriusXM Common Stock
LSXMB
$0 ﹤0.01%
1
BIMI
6517
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
$0 ﹤0.01%
4
DYNT
6518
DELISTED
Dynatronics Corp
DYNT
0
DMTK
6519
DELISTED
DermTech, Inc. Common Stock
DMTK
-1
Closed
ISUN
6520
DELISTED
iSun, Inc. Common Stock
ISUN
$0 ﹤0.01%
1
AVGR
6521
DELISTED
Avinger, Inc. Common Stock
AVGR
0
ENG
6522
DELISTED
ENGlobal Corp
ENG
$0 ﹤0.01%
8
-5
-38% -$34
OPGN
6523
DELISTED
OpGen, Inc
OPGN
0
YTEN
6524
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
0
GGE
6525
DELISTED
Green Giant Inc. Common Stock
GGE
$0 ﹤0.01%
2
-4,700
-100% -$14.5K

Similar funds

Morgan Stanley's Q1 2018 Portfolio in Review

As of Q1 2018, Morgan Stanley held 6,930 positions worth $360B, down 1.4% from $365B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q1 2018: portfolio turnover was 4.7%. Morgan Stanley opened 170 new positions and exited 155, leaving the 6,930-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Morgan Stanley's largest Q1 2018 buy was Nutrien: 1,554,481 shares worth $73.5M.
  • Morgan Stanley added most to iShares Russell 2000 ETF in Q1 2018, an estimated $1.27B increase.
  • Morgan Stanley's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.33B.
  • Morgan Stanley fully exited Juno Therapeutics, Inc. in Q1 2018, selling an estimated $86M.
  • Morgan Stanley's ten largest holdings make up 14% of its $360B portfolio in Q1 2018.
  • Morgan Stanley opened 170 new positions and closed 155 in Q1 2018.
  • Morgan Stanley's portfolio value fell 1.4% quarter-over-quarter to $360B.

Based on Morgan Stanley's 13F filing for Q1 2018, filed 14 May 2018.